EUVIMEDEUVIMED entdecken
Crossref

Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse)

Sang Wook Kang, Ju Yeon Ban, Min Su Park

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.03.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Sang Wook Kang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea. Electronic address: ifthisplus88@hanmail.net. Hauptthemen laut MEDLINE: Reperfusion Injury, Sirolimus, Mice, Inbred C57BL, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver ischemia/reperfusion injury (IRI) is a well-documented phenomenon that occurs after liver resection and transplantation, posing a significant clinical challenge. We aim to contribute valuable insights into potential therapeutic interventions for fibrotic liver IRI, ultimately advancing our understanding of liver transplantation and resection outcomes. METHODS: Twenty-four mice were divided randomly into 4 equal groups: [1] the normal group, n = 6; [2] the liver fibrosis (LF) group, n = 6; [3] the LF and IR group, n = 6; and [4] the LF with treatment of rapamycin and IR group; n = 6. RESULTS: Key biomarkers assessing liver function, alanine aminotransferase and aspartate aminotransferase, significantly decreased with Rapamycin administration. There is a substantial decrease observed in inflammatory cytokines such as interleukin (IL) 6, IL-1B, tumor necrosis factor alpha, Transforming growth factor-beta (TGF-beta), and Inducible nitric oxide synthase (iNOS) with rapamycin treatment. Furthermore, NOX levels, caspase-3, and caspase-9 were reduced after rapamycin administration. CONCLUSION: The application of rapamycin demonstrates appropriate effects in anti-inflammation, antioxidation, and anti-apoptosis, indicating significant therapeutic potential for fibrotic liver IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjurySirolimusMice, Inbred C57BLLiver CirrhosisAnimalsMiceLiverMaleCytokinesApoptosisAspartate AminotransferasesAlanine TransaminaseNitric Oxide Synthase Type II

Substanzen

SirolimusCytokinesAspartate AminotransferasesAlanine TransaminaseNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Department of Oral Pathology, School of Dentistry, Kyung Hee University, Seoul, Republic of Korea. Electronic address: ifthisplus88@hanmail.net.
  • Department of Dental Pharmacology, College of Dentistry, Dankook University, Cheonan, Republic of Korea. Electronic address: jyban@dankook.ac.kr.
  • Department of Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea. Electronic address: ikireida@gmail.com.

Zitieren

APA

Kang, S. W., Ban, J. Y., & Park, M. S. (2024). Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse). Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.03.005

Vancouver

Kang SW, Ban JY, Park MS. Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse). Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.03.005

BibTeX
@article{Kang2024,
  author = {Kang, Sang Wook and Ban, Ju Yeon and Park, Min Su},
  title = {Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse)},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.03.005}
}
Kostenlos starten →